Genetics and Psychopathology in the 22q11 Deletion Syndrome

NCT00161109 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2006-10-13

No results posted yet for this study

Summary

The purposes of this study are to:

1. study the nature and longitudinal course of psychiatric symptoms in children with the 22q11.2 deletion syndrome and
2. identify genes that contribute to the occurrence of these symptoms.

Conditions

  • Chromosome 22q11.2 Deletion Syndrome

Sponsors & Collaborators

Principal Investigators

  • René S. Kahn, M.D., Ph.D. · UMC Utrecht, The Netherlands

Eligibility

Min Age
8 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-10-31
Completion
2012-10-31

Countries

  • United States
  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00161109 on ClinicalTrials.gov